Nationwide Children's Research News

Nov 15, 2013

Pediatric Biomedical Research Bill Passes Congress

A bill eight years in the making to strengthen pediatric biomedical research is headed to President Obama’s desk to be signed into law. The legislation, known as the National Pediatric Research Network Act and strongly supported by The Research Institute at Nationwide Children’s

Nov 14, 2013

Genetic Signature Identified for RSV, the Leading Cause of Infant Hospitalizations Worldwide

Scientists have identified the genetic signature of respiratory syncytial virus (RSV), the leading cause of infant hospitalizations around the world. The work is a key step toward a better understanding of the immune response to RSV, which will aid the development of a vaccine and a tool that could

Nov 06, 2013

Findings Announced from Landmark Study on Safety of Adolescent Bariatric Surgery

Initial results of a first and largest of its kind study focusing on the safety of adolescent bariatric surgery were published this week in JAMA Pediatrics.

Nov 04, 2013

Abusive Head Trauma Injuries Linked to Socioeconomic Status, Age and Gender

A new study estimates that more than seven children under the age of five with abusive head trauma were treated each day in U.S. emergency departments between 2006 and 2009.

Oct 30, 2013

Study: Researchers Identify Way to Increase Gene Therapy Success

Scientists in The Research Institute at Nationwide Children’s Hospital have found a way to overcome one of the biggest obstacles to using viruses to deliver therapeutic genes: how to keep the immune system from neutralizing the virus before it can deliver its genetic payload.

Oct 18, 2013

AveXis- BioLife Licenses Spinal Muscular Atrophy (SMA) Patent Portfolio from Nationwide Childrens Hospital and The Ohio State University

BioLife, a synthetic biology platform company soon to be renamed AveXis, has been granted exclusive rights to the spinal muscular atrophy gene therapy program developed at The Research Institute at Nationwide Children’s Hospital and The Ohio State University in Columbus, Ohio.

Oct 08, 2013

$25.4 Million Awarded to Center for Clinical and Translational Science to Continue Critical Bench to Bedside Translational Research

The National Institutes of Health has awarded a $25.4 million grant to the Center for Clinical and Translational Science (CCTS), a collaboration between The Ohio State University and Nationwide Children’s Hospital created to accelerate basic science discoveries into life-saving medical

Sep 25, 2013

Nationwide Children's Hospital Awarded $250,000 Childhood Cancer Research Grant from Hyundai Hope On Wheels

Hyundai Hope On Wheels® and Central Ohio Hyundai dealers will today award Nationwide Children’s Hospital with a $250,000 Hyundai Hope Grant for pediatric cancer research.

Sep 09, 2013

Therapy Slows Onset and Progression of Lou Gehrigs Disease, Study Finds

Studies of a therapy designed to treat amyotrophic lateral sclerosis (ALS) suggest that the treatment dramatically slows onset and progression of the deadly disease, one of the most common neuromuscular disorders in the world.

Sep 04, 2013

Study Examines Ways to Restore Immunity to Chronic Hepatitis C Infection

The hepatitis C virus hijacks the body’s immune system, leaving T cells unable to function. A new study in animal models suggests that blocking a protein that helps the virus thrive could restore immune function, allowing the body to fight infection.